In 2010, life expectancy in Botswana is expected to drop to about 30 years if the AIDS epidemic remains unchecked. In Canada, life expectancy is over 80 years and rising. Such shocking inequities in health are perhaps today's greatest ethical challenge. Can the unfolding revolution in genomics (the study not of individual genes but of all genes as an entity) and biotechnology be harnessed to reduce these inequities? We believe the answer is a qualified "yes," if certain conditions are met.
First, we must not mistakenly view genomics/biotechnology as "high-tech," expensive and therefore irrelevant for developing countries. Vaccines were and still are high-tech, but their cost has come down and they have made a huge impact in developing countries. In many developing nations, genetic disorders are among the top public health priorities. The ongoing sequencing of the genomes of malaria, the tubercle bacillus, leprosy, hepatitis viruses and HIV raises serious hopes of better vaccines in the future. A vaccine against HIV is already being tested in Kenya. Edible vaccines from transgenic plants are likely to be more useful for developing countries than for developed ones because they avoid the need for refrigeration.
Second, developing-country concerns must be kept at the forefront of discussions about the potential benefits of genomics and biotechnology. People who protest against globalization in places like Genoa are unlikely to die of hunger in Somalia. The voices of people in developing countries must be heard. For example, Hassan Adamu, Nigeria's former minister of agricultural and rural development has noted: "It is possible to kill someone with kindness, literally. That could be the result of the well-meaning but extremely misguided attempts by European and North American groups that advise Africans to be wary of agricultural biotechnology."
Third, we must build on the research strengths and human capital of developing countries. For example, Cuba has a significant biotechnology industry: it developed the only effective meningitis B vaccine (which, despite the embargo, is imported into the US), and in 1998 it produced 30 tonnes of transgenic tilapia fish. Income from Cuba's biotechnology exports is sufficient to sustain Cuba's biotech research and development expenditure.
India, Brazil, China and several other developing countries also have serious research-and-development efforts in biotechnology. Developing countries must also build capacity for policy analysis and ethics. The African Center for Technology Studies in Nairobi is influential internationally and already plays an important policy research and capacity-strengthening role.
It recently became clear that one key to success is to forge mutually beneficial collaborations with well established and successful institutions wherever they may be, not just between neighboring countries. One of the developing world's least leveraged resources is its human capital working overseas, often in leadership positions in academia and industry. India successfully drew from this resourceful pool in the "diaspora" to become one of the world's leading exporters of software.
Fourth, we must broaden the concept of human security, introduced into the UN Security Council by Canada in recent years, to include not only protection of civilians in military conflict but also protection of civilians from health threats. Linking genomics, global health is not only a scientific and policy issue, but also a diplomatic one.
We collectively need to make a positive policy decision to capitalize on the potential of genomics/biotechnology to help reduce inequities in global health. Ultimately, it will be necessary to crystallize the many lessons learnt in a format that is easily digestible. The effort should bring together industry, academia, the media, NGOs, and governments to alleviate suspicion, facilitate dialogue, build trust, arrive at consensuses and agree on good practice guidelines. This should harmonize the approach toward the application of genomics and biotechnology to solve major health problems worldwide.
An early indicator of success will be when the global discourse on biotechnology focuses on the benefits as well as the risks, and on the concerns of both the developing and developed world. In the long run this may translate into a reduction in the avoidable burden of disease and better health indicators. If we act, Botswana's life expectancy may one day be closer to 80 than to 30 after all.
Peter A. Singer is Sun Life Chair and director of the University of Toronto Joint Centre for Bioethics. Abdallah S. Daar is director of the Centre's Program in Applied Ethics and Biotechnology and a member of the Ethics Committee of the Human Genome Organization.
Copyright: Project Syndicate
A series of strong earthquakes in Hualien County not only caused severe damage in Taiwan, but also revealed that China’s power has permeated everywhere. A Taiwanese woman posted on the Internet that she found clips of the earthquake — which were recorded by the security camera in her home — on the Chinese social media platform Xiaohongshu. It is spine-chilling that the problem might be because the security camera was manufactured in China. China has widely collected information, infringed upon public privacy and raised information security threats through various social media platforms, as well as telecommunication and security equipment. Several former TikTok employees revealed
Two sets of economic data released last week by the Directorate-General of Budget, Accounting and Statistics (DGBAS) have drawn mixed reactions from the public: One on the nation’s economic performance in the first quarter of the year and the other on Taiwan’s household wealth distribution in 2021. GDP growth for the first quarter was faster than expected, at 6.51 percent year-on-year, an acceleration from the previous quarter’s 4.93 percent and higher than the agency’s February estimate of 5.92 percent. It was also the highest growth since the second quarter of 2021, when the economy expanded 8.07 percent, DGBAS data showed. The growth
At the same time as more than 30 military aircraft were detected near Taiwan — one of the highest daily incursions this year — with some flying as close as 37 nautical miles (69kms) from the northern city of Keelung, China announced a limited and selected relaxation of restrictions on Taiwanese agricultural exports and tourism, upon receiving a Chinese Nationalist Party (KMT) delegation led by KMT legislative caucus whip Fu Kun-chi (傅崑萁). This demonstrates the two-faced gimmick of China’s “united front” strategy. Despite the strongest earthquake to hit the nation in 25 years striking Hualien on April 3, which caused
In the 2022 book Danger Zone: The Coming Conflict with China, academics Hal Brands and Michael Beckley warned, against conventional wisdom, that it was not a rising China that the US and its allies had to fear, but a declining China. This is because “peaking powers” — nations at the peak of their relative power and staring over the precipice of decline — are particularly dangerous, as they might believe they only have a narrow window of opportunity to grab what they can before decline sets in, they said. The tailwinds that propelled China’s spectacular economic rise over the past